CHAMPIONS ONCOLOGY INC
For the period ended Apr 30, 2024. Filed Jul 19, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Jul 19, 2024
CSBR$4.75-1.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
(Dollars in Thousands)
| Year Ended April 30, | ||
|---|---|---|
| 2024 | 2023 | |
| Operating activities: | ||
| Net loss | $(7,276) | $(5,335) |
| Adjustments to reconcile net loss to net cash (used in) provided by operating activities: | ||
| Stock-based compensation expense | 1,118 | 864 |
| Depreciation and amortization expense | 1,867 | 2,246 |
| Net loss on disposal of equipment | 435 | — |
| Operating lease right-of-use assets | 1,066 | 952 |
| Asset impairment | — | 807 |
| Allowance for doubtful accounts and estimated credit losses | 476 | 195 |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | (1,991) | 1,308 |
| Prepaid expenses and other current assets | (167) | (184) |
| Other long term assets | (169) | — |
| Accounts payable | 465 | 2,465 |
| Accrued liabilities | (109) | (145) |
| Operating lease liabilities | (1,169) | (907) |
| Deferred revenue | (683) | 1,706 |
| Net cash (used in) provided by operating activities | (6,137) | 3,972 |
| Investing activities: | ||
| Purchase of property and equipment | (836) | (2,872) |
| Net cash used in investing activities | (836) | (2,872) |
| Financing activities: | ||
| Proceeds from exercise of options | 253 | 85 |
| Repurchases of common stock | (634) | (74) |
| Finance lease payments | (146) | — |
| Net cash (used in) provided by financing activities | (527) | 11 |
| (Decrease) increase in cash | (7,500) | 1,111 |
| Cash, beginning of year | 10,118 | 9,007 |
| Cash, end of year | $2,618 | $10,118 |
| Non-cash financing and investing activities: | ||
| Purchased equipment under finance lease | — | 368 |
| Right-of-use assets obtained in exchange for operating lease liabilities | $— | $231 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.